Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics Signs Eisenberg as Israel Distributor

NEW YORK – S2 Genomics said on Tuesday that it has signed a distribution agreement with life sciences distribution firm Eisenberg Bros. (Eisenberg) for Israel.

Under the terms of the agreement, Eisenberg will promote, sell, and support S2's Singulator 100 tissue dissociation instrument for sample preparation in single-cell genomics.

Financial and other details were not disclosed.

"Israel is a thriving market for single-cell genomics and cell biology research, creating a need for improved single-cell preparation solutions," S2 CEO Stevan Jovanovich, said in a statement. "We are excited to welcome Eisenberg as a key partner for S2 Genomics. Eisenberg is a premier life sciences distributor for Israel, and expanding our commercialization efforts with them represents a significant milestone for S2 Genomics."

Livermore, California-based S2 sells the Singulator 100 system for isolation of single cells or nuclei from solid tissue samples. Earlier this year, the firm signed a joint marketing agreement with Applied Cells.

In 2020, the firm signed distribution deals for Canada, Japan, South Korea, Taiwan, Australia, and New Zealand.

S2 also has collaborated with Dolomite Bio on automated single-cell library prep and Japan's RIKEN on single-cell genomics.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.